APA (7th ed.) Citation

A, A., Y, K., M, B., H, v. d. W., D, W., T, Z., . . . JA, R. (2023). The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease. Biomolecules, 13(9), . https://doi.org/10.3390/biom13091303

Chicago Style (17th ed.) Citation

A, Albus, Kronimus Y, Burg-Roderfeld M, van der Wurp H, Willbold D, Ziehm T, Dodel R, and Ross JA. "The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease." Biomolecules 13, no. 9 (2023). https://doi.org/10.3390/biom13091303.

MLA (9th ed.) Citation

A, Albus, et al. "The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease." Biomolecules, vol. 13, no. 9, 2023, https://doi.org/10.3390/biom13091303.